Wells Fargo’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Wells Fargo's CNMD Position: Q1 2026 in Review
Wells Fargo reduced its CONMED (CNMD) stake by 44% in Q1 2026, selling an estimated $3.03M and leaving 96,369 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2884.
Wells Fargo first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.6M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Wells Fargo held 96,369 shares of CONMED worth $3.41M as of Q1 2026.
- Wells Fargo sold 74,449 CONMED shares in Q1 2026, an estimated $3.03M.
- CONMED made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2884 holding.
- Wells Fargo first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's CONMED position peaked at $85.6M in Q2 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.